Free Trial

EDAP TMS (EDAP) Competitors

EDAP TMS logo
$1.67 +0.02 (+1.21%)
As of 09:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EDAP vs. ZIMV, SMTI, TCMD, STIM, NVRO, TLSI, SGHT, BWAY, DRTS, and SKIN

Should you be buying EDAP TMS stock or one of its competitors? The main competitors of EDAP TMS include ZimVie (ZIMV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), Neuronetics (STIM), Nevro (NVRO), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Brainsway (BWAY), Alpha Tau Medical (DRTS), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.

EDAP TMS vs. Its Competitors

ZimVie (NASDAQ:ZIMV) and EDAP TMS (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

EDAP TMS has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than EDAP TMS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZimVie$449.75M0.58-$25.83M-$0.71-13.25
EDAP TMS$69.18M0.90-$20.58M-$0.62-2.69

ZimVie has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500. Comparatively, EDAP TMS has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500.

ZimVie presently has a consensus price target of $16.33, suggesting a potential upside of 73.57%. EDAP TMS has a consensus price target of $8.50, suggesting a potential upside of 408.98%. Given EDAP TMS's higher probable upside, analysts plainly believe EDAP TMS is more favorable than ZimVie.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZimVie
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.67
EDAP TMS
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

ZimVie has a net margin of -4.40% compared to EDAP TMS's net margin of -34.45%. ZimVie's return on equity of 5.53% beat EDAP TMS's return on equity.

Company Net Margins Return on Equity Return on Assets
ZimVie-4.40% 5.53% 2.84%
EDAP TMS -34.45%-51.42%-26.43%

95.6% of ZimVie shares are owned by institutional investors. Comparatively, 62.7% of EDAP TMS shares are owned by institutional investors. 5.4% of ZimVie shares are owned by insiders. Comparatively, 0.2% of EDAP TMS shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, ZimVie and ZimVie both had 3 articles in the media. EDAP TMS's average media sentiment score of 0.94 beat ZimVie's score of 0.62 indicating that EDAP TMS is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZimVie
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
EDAP TMS
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

ZimVie beats EDAP TMS on 9 of the 16 factors compared between the two stocks.

Get EDAP TMS News Delivered to You Automatically

Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDAP vs. The Competition

MetricEDAP TMSMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$62.44M$6.74B$5.45B$8.90B
Dividend YieldN/A1.03%5.36%4.14%
P/E Ratio-2.6926.6326.4219.67
Price / Sales0.90104.08406.85110.35
Price / CashN/A21.4025.8827.49
Price / Book1.424.757.915.42
Net Income-$20.58M$171.62M$3.15B$248.34M
7 Day Performance-4.02%-0.74%0.62%0.81%
1 Month Performance-6.18%9.01%4.94%5.01%
1 Year Performance-68.01%20.13%32.26%18.10%

EDAP TMS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDAP
EDAP TMS
2.9643 of 5 stars
$1.67
+1.2%
$8.50
+409.0%
-69.7%$62.44M$69.18M-2.69230News Coverage
ZIMV
ZimVie
2.46 of 5 stars
$8.65
-1.6%
$16.33
+88.8%
-48.8%$244.78M$449.75M-12.181,770
SMTI
Sanara MedTech
2.2155 of 5 stars
$27.82
+2.0%
$49.50
+77.9%
+0.6%$242.46M$86.67M-20.7660
TCMD
Tactile Systems Technology
3.2953 of 5 stars
$10.17
+2.0%
$16.00
+57.3%
-15.1%$231.79M$292.98M15.411,037
STIM
Neuronetics
2.5468 of 5 stars
$3.43
-0.9%
$5.50
+60.3%
+93.9%$227.74M$74.89M-2.62180Positive News
NVRO
Nevro
0.1778 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-30.6%$224.32M$408.52M-3.091,090
TLSI
TriSalus Life Sciences
3.1057 of 5 stars
$5.29
-5.4%
$10.75
+103.2%
-1.3%$211.52M$29.43M-4.72106Gap Down
SGHT
Sight Sciences
1.1713 of 5 stars
$4.34
+6.9%
$4.10
-5.5%
-38.1%$209.88M$79.87M-4.43210Analyst Upgrade
BWAY
Brainsway
1.4512 of 5 stars
$11.49
+5.3%
$14.25
+24.0%
+116.6%$206.14M$41.02M57.45120
DRTS
Alpha Tau Medical
2.5335 of 5 stars
$2.98
+2.8%
$8.00
+168.5%
+23.3%$204.10MN/A-6.4880
SKIN
Beauty Health
0.3372 of 5 stars
$1.93
+19.9%
$1.42
-26.6%
-0.5%$202.85M$334.30M-4.711,030High Trading Volume

Related Companies and Tools


This page (NASDAQ:EDAP) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners